Toxic Exposure · Roundup
Roundup
Monsanto/Bayer Roundup (glyphosate) — non-Hodgkin lymphoma
Roundup, the world's most widely used herbicide, contains glyphosate — an active ingredient the International Agency for Research on Cancer (IARC) classified in 2015 as 'probably carcinogenic to humans.' Landscapers, farmers, agricultural workers, and home users diagnosed with non-Hodgkin lymphoma have brought tens of thousands of cases against Monsanto and its parent, Bayer.
Background
What this litigation is about.
Roundup was introduced by Monsanto in 1974. In 2015, IARC classified glyphosate as Group 2A — 'probably carcinogenic to humans,' with strongest evidence for non-Hodgkin lymphoma.
The first bellwether trial, Johnson v. Monsanto (California state court, 2018), resulted in a $289M plaintiff verdict (later reduced). Hardeman v. Monsanto (N.D. Cal., 2019) and Pilliod v. Monsanto (California state court, 2019) followed with additional large plaintiff verdicts.
In 2020, Bayer (which acquired Monsanto in 2018) announced an approximately $10 billion global settlement framework covering the majority of pending U.S. Roundup claims and setting up a program for future claims. Additional individual cases have proceeded to trial with mixed outcomes, and litigation continues.
Reported injuries
Complications documented in this litigation.
Non-Hodgkin lymphoma (NHL)
The primary diagnosis in Roundup litigation — including diffuse large B-cell lymphoma, follicular lymphoma, and others.
Chronic lymphocytic leukemia (CLL)
A form of NHL recognized in the litigation.
Mantle cell lymphoma
Another NHL subtype tied to glyphosate exposure.
Multiple myeloma
Some claims involve multiple myeloma, though evidence is more contested.
Who may qualify
An honest self-check.
You used Roundup or another glyphosate-based herbicide regularly — at work (landscaping, agriculture, grounds crew) or heavily at home — over a period of years.
You have been diagnosed with non-Hodgkin lymphoma or a related lymphatic cancer.
You have pathology and treatment records confirming the diagnosis.
You can approximate the years, frequency, and setting of your exposure.
Key events
A timeline of what has happened so far.
1974
Monsanto introduces Roundup (glyphosate) herbicide.
Mar 2015
IARC classifies glyphosate as 'probably carcinogenic to humans' (Group 2A).
Oct 2016
JPML consolidates federal Roundup cases as MDL 2741 in N.D. Cal. before Judge Chhabria.
Aug 2018
Johnson v. Monsanto — first bellwether, $289M plaintiff verdict (later reduced).
2018
Bayer acquires Monsanto for ~$63B.
Mar 2019
Hardeman v. Monsanto — federal bellwether plaintiff verdict of ~$80M.
May 2019
Pilliod v. Monsanto — California state jury awards ~$2B (later reduced).
Jun 2020
Bayer announces ~$10B global settlement framework.
2021–2026
Continued individual trials with mixed verdicts; new intake continues for eligible NHL claims.
Frequently asked
Questions answered plainly.
Information current as of 2026. This page is for general information only, is not legal advice, and does not create an attorney-client relationship. Case statuses, MDL orders, and settlement terms change; call our office for a current review of your specific situation.
Free · Confidential · No obligation
Not sure whether you have a case? Start with a conversation.
Tell us what happened, at your pace. We will listen, answer honestly, and — if we can help — begin quietly, right away.